首页 | 本学科首页   官方微博 | 高级检索  
检索        


The GOLD ReGISTry: a Global,Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours
Institution:1. PUCRS School of Medicine, Porto Alegre, Brazil;2. Mount Sinai Hospital, Toronto, ON, Canada;3. Universite Claude Bernard, Lyon, France;4. Istituto Nazionale Tumori, Milan, Italy;5. Alexander Fleming Institute, Department of Medical Oncology, Buenos Aires, Argentina;6. Peking University Cancer Hospital, Beijing, China;7. University of Ulsan College of Medicine, Seoul, South Korea;8. National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan;9. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;10. HELIOS Klinikum Berlin-Buch, Berlin, Germany
Abstract:
Keywords:CD117 (c-KIT)-positive gastrointestinal stromal tumour (GIST)  Global cancer registry  Imatinib  Tyrosine kinase inhibitor  Long-term outcomes  Patient management  Mutational analysis  Localised  Advanced  Adjuvant
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号